# Safety, Blood Levels, Drug Interaction and Effects of Repeated Doses of GSK1034702

> **NCT00950586** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 48 (actual)

## Conditions studied

- Cognitive Disorders

## Interventions

- **DRUG:** GSK1043702
- **DRUG:** Dextromethorphan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00950586
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08-24
- **Primary completion:** 2009-12-24
- **Final completion:** 2009-12-24
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2017-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00950586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00950586, "Safety, Blood Levels, Drug Interaction and Effects of Repeated Doses of GSK1034702". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00950586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*